Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yasuhiko Kanagawa"'
Autor:
Hiroshi Yamaguchi, Midori Kato, Yasumasa Ikeda, Tomoko Arase, Yasuhiko Kanagawa, Shuji Kato, Tomonori Yoshida, Masashi Akaike, Toshio Matsumoto, Ken-ichi Aihara, Mitsunori Fujimura, Shunji Hashizume, Nobuyuki Takamori, Akira Kondo, Hiroyuki Azuma
Publikováno v:
Circulation. 109:2761-2765
Background— Thrombin plays a crucial role in atherothrombotic changes. Because heparin cofactor II (HCII) inhibits thrombin actions after binding to dermatan sulfate at injured arterial walls, HCII may negatively regulate thrombin actions in vascul
Autor:
Masashi Akaike, Tomonori Yoshida, Katsuya Tamura, Takeshi Nishiuchi, Toshio Matsumoto, Takahiko Iuchi, Ken-ichi Aihara, Ikuro Hayashi, Yasuhiko Kanagawa, Hiroyuki Azuma, Ayako Kagawa, Nobuyuki Takamori, Kazuya Matsumoto
Publikováno v:
Clinical Chemistry. 48:1454-1459
Background: Increased serum lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerosis. We previously reported that aspirin reduced Lp(a) production by cultured hepatocytes via the reduction of apolipoprotein(a) [apo(a)] gene transcript
Autor:
Masaru Nagayama, Mitsuyoshi Minami, Yasuhiko Kanagawa, Hiroaki Nakanishi, Takashi Hashimoto, Kazuhito Satomura, Reiko Tokuyama, Nobuyuki Kamata, Takashi Sumitomo
Publikováno v:
Journal of Japanese Society for Oral Mucous Membrane. 8:68-75
Autor:
Ken-ichi Aihara, Toshio Shigekiyo, Masashi Akaike, Toshio Matsumoto, Hiroyuki Azuma, Yasuhiko Kanagawa
Publikováno v:
Thrombosis and Haemostasis. 85:101-107
SummaryWe found a 66-year-old Japanese patient with type I congenital heparin cofactor (HC) II deficiency manifesting multiple atherosclerotic lesions. To investigate the molecular pathogenesis of our patient, we performed sequencing analysis and exp
Publikováno v:
Journal of Thrombosis and Haemostasis. 1:1314-1316
Autor:
Yasuhiko Kanagawa, Sadao Wakabayashi, Koichi Satoh, Toshio Shigekiyo, Toshio Matsumoto, Hidemasa Yoshida, Takehiko Koide
Publikováno v:
Thrombosis and haemostasis. 84(4)
SummaryThe proband, a 76-year-old woman, suffered from dural arteriovenous fistula. Her plasma histidine-rich glycoprotein (HRG) level was 50% of the normal level. A low level of plasma HRG was also found in her third daughter. A single nucleotide su
Publikováno v:
The Journal of biological chemistry. 274(48)
High serum lipoprotein(a) (Lp(a)) is a risk factor for vascular disorders. Our preliminary observations suggest that, in some patients with coronary heart disease with high serum Lp(a) levels, administration of aspirin reduced Lp(a) levels. Therefore
Autor:
Shiro Saito, Kazumasa Miyamoto, Ayako Watanabe, Nobuaki Mima, Hiroyuki Azuma, Hiroshi Yamaguchi, Yasuhiko Kanagawa, Toshio Shigekiyo, Mitsuo Shirakawa
Publikováno v:
Biochemical and biophysical research communications. 227(2)
A high serum concentration of lipoprotein(a) [Lp(a)] is a significant and independent risk factor for cardiovascular disease. We examined the effects of agents on the transcriptional activity of the apolipoprotein(a) [apo(a)] gene promoter and determ